Skip to main content

CORRECTION article

Front. Oncol., 25 February 2020
Sec. Radiation Oncology

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

  • 1Department of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom
  • 2Radiation Physics, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden

A Corrigendum on
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

by Wilson, J. D., Hammond, E. M., Higgins, G. S., and Petersson, K. (2020). Front. Oncol. 9:1563. doi: 10.3389/fonc.2019.01563

In the original article, there was an error. Hydroxyl radicals are mentioned on four occasions in the text. It should be free radicals and not hydroxyl.

A correction has been made to the Hypotheses To Explain The Flash Effect section, subsection Oxygen Depletion Hypothesis, paragraphs 1 and 3.

“The biological mechanism responsible for the reduction in normal tissue toxicities following irradiation at FLASH dose rates is not currently understood, yet several non-mutually exclusive hypotheses have been proposed. Some researchers have suggested that the differential response between FLASH-RT and CONV-RT may be due to the radiochemical depletion of oxygen at ultra-high dose rates and subsequent radioresistance conferred to the irradiated tissue (32, 38, 39). It is widely accepted that hypoxic tissues are more radioresistant than well-oxygenated tissues. This is because in the presence of molecular oxygen there is fixation of indirect radiation-induced DNA damage. Indirect damage, the predominant mechanism by which low linear energy transfer (LET) radiation induces DNA damage, occurs when radiation results in the radiolysis of water molecules and the subsequent generation of free radicals. Free radicals are then incorporated into DNA, causing damage—yet this can be easily resolved. However, if a free radical reacts with molecular oxygen, this yields a peroxyl radical. Peroxyl radicals have the potential to induce permanent damage, and are therefore a more efficacious DNA damaging agent. Hence, a lack of oxygen in the immediate environment of a cell limits the extent of radiation-induced DNA damage (40).

A relationship between dose rate and oxygen consumption was proposed by Dewey and Boag in 1959 (44). They demonstrated that bacteria irradiated at ultra-high dose rates had greater survival compared to bacteria irradiated at what we now consider to be conventional dose rates. The survival curve generated following ultra-high dose rate irradiation was indicative of bacteria irradiated in a hypoxic environment. The authors hypothesized at the time that this response was a consequence of oxygen depletion following a large dose of radiation in such a short timeframe; the time for which the bacteria were irradiated for was shorter than the time required for oxygen to diffuse and restore the oxygen that had been depleted. Given that molecular oxygen is depleted as it reacts with free radicals generated from the radiolysis of water, irradiation at ultra-high dose rates is able to significantly deplete oxygen before it can replenish. This gives rise to a small window of radiobiological hypoxia”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: FLASH, radiotherapy, hypoxia, normal tissue, immune

Citation: Wilson JD, Hammond EM, Higgins GS and Petersson K (2020) Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold? Front. Oncol. 10:210. doi: 10.3389/fonc.2020.00210

Received: 04 February 2020; Accepted: 06 February 2020;
Published: 25 February 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Wilson, Hammond, Higgins and Petersson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kristoffer Petersson, kristoffer.petersson@oncology.ox.ac.uk

ORCID: Joseph D. Wilson orcid.org/0000-0001-8878-5882
Ester M. Hammond orcid.org/0000-0002-2335-3146
Geoff S. Higgins orcid.org/0000-0003-3072-909X
Kristoffer Petersson orcid.org/0000-0003-0300-5790

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.